MaxQ Research Awarded Phase I SBIR Contract by Defense Health Agency
MaxQ has been awarded a Phase I SBIR contract from the United States Defense Health Agency (DHA) SBIR/STTR Program to help address the challenges faced by the U.S. Armed Services Blood Program (ASBP)